{"entity":{"type":"insider","cik":"0001602484","url":"/insider/0001602484","json_url":"/insider/0001602484.json","name":"SCP Vitalife Partners (Israel) II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":23,"first":"2015-11-25","last":"2020-12-28","span_basis":"filed_date"},"name_variants":[{"name":"SCP Vitalife Partners (Israel) II, L.P.","source":"filing","n_filings":23,"first_seen":"2015-11-25","last_seen":"2020-12-28"}],"transactions":[{"id":3232663,"accession":"0001192482-20-000850","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000850","line_url":"/filing/0001192482-20-000850#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18830.0,"shares_display":"18,830","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":59691.1,"total_display":"59,691.10","total_whole":"59,691","shares_owned_after":701017.0,"shares_owned_after_display":"701,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-28","scope":"insider"},{"id":2940639,"accession":"0001192482-20-000846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000846","line_url":"/filing/0001192482-20-000846#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6208.0,"shares_display":"6,208","price_per_share":3.0304,"price_display":"3.03","price_state":"stated","total_value":18812.7232,"total_display":"18,812.72","total_whole":"18,813","shares_owned_after":719847.0,"shares_owned_after_display":"719,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":6096246,"accession":"0001192482-18-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000033","line_url":"/filing/0001192482-18-000033#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1579.0,"shares_display":"1,579","price_per_share":8.8382,"price_display":"8.84","price_state":"stated","total_value":13955.5178,"total_display":"13,955.52","total_whole":"13,956","shares_owned_after":726055.0,"shares_owned_after_display":"726,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":6253489,"accession":"0001192482-18-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-18-000010","line_url":"/filing/0001192482-18-000010#line-2","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6635.0,"shares_display":"6,635","price_per_share":8.733,"price_display":"8.73","price_state":"stated","total_value":57943.455,"total_display":"57,943.46","total_whole":"57,943","shares_owned_after":727634.0,"shares_owned_after_display":"727,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-04","scope":"insider"},{"id":6253487,"accession":"0001192482-18-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000010","line_url":"/filing/0001192482-18-000010#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6329.0,"shares_display":"6,329","price_per_share":9.037,"price_display":"9.04","price_state":"stated","total_value":57195.173,"total_display":"57,195.17","total_whole":"57,195","shares_owned_after":734269.0,"shares_owned_after_display":"734,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":6231772,"accession":"0001192482-18-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-18-000002","line_url":"/filing/0001192482-18-000002#line-2","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4110.0,"shares_display":"4,110","price_per_share":9.1948,"price_display":"9.19","price_state":"stated","total_value":37790.628,"total_display":"37,790.63","total_whole":"37,791","shares_owned_after":740598.0,"shares_owned_after_display":"740,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2018-01-02","scope":"insider"},{"id":6231762,"accession":"0001192482-18-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000002","line_url":"/filing/0001192482-18-000002#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1980.0,"shares_display":"1,980","price_per_share":9.4395,"price_display":"9.44","price_state":"stated","total_value":18690.21,"total_display":"18,690.21","total_whole":"18,690","shares_owned_after":744708.0,"shares_owned_after_display":"744,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-28","filed_date":"2018-01-02","scope":"insider"},{"id":5154341,"accession":"0001192482-17-000329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-17-000329","line_url":"/filing/0001192482-17-000329#line-2","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2803.0,"shares_display":"2,803","price_per_share":9.5388,"price_display":"9.54","price_state":"stated","total_value":26737.2564,"total_display":"26,737.26","total_whole":"26,737","shares_owned_after":746688.0,"shares_owned_after_display":"746,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-27","filed_date":"2017-12-28","scope":"insider"},{"id":5154335,"accession":"0001192482-17-000329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-17-000329","line_url":"/filing/0001192482-17-000329#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1602.0,"shares_display":"1,602","price_per_share":9.5906,"price_display":"9.59","price_state":"stated","total_value":15364.1412,"total_display":"15,364.14","total_whole":"15,364","shares_owned_after":749491.0,"shares_owned_after_display":"749,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-28","scope":"insider"},{"id":5247527,"accession":"0001144204-17-034636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-034636","line_url":"/filing/0001144204-17-034636#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife II Associates, L.P.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J; SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.","owner_display_name":"SCP Vitalife II Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12511.0,"shares_display":"12,511","price_per_share":3.0931,"price_display":"3.09","price_state":"stated","total_value":38697.7741,"total_display":"38,697.77","total_whole":"38,698","shares_owned_after":339900.0,"shares_owned_after_display":"339,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-27","filed_date":"2017-06-28","scope":"insider"},{"id":5247523,"accession":"0001144204-17-034636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-034636","line_url":"/filing/0001144204-17-034636#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife II Associates, L.P.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J; SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.","owner_display_name":"SCP Vitalife II Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9271.0,"shares_display":"9,271","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":27813.0,"total_display":"27,813.00","total_whole":"27,813","shares_owned_after":352411.0,"shares_owned_after_display":"352,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-28","scope":"insider"},{"id":4528784,"accession":"0001123292-17-000694","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-17-000694","line_url":"/filing/0001123292-17-000694#line-3","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3170.0,"shares_display":"3,170","price_per_share":7.9258,"price_display":"7.93","price_state":"stated","total_value":25124.786,"total_display":"25,124.79","total_whole":"25,125","shares_owned_after":751093.0,"shares_owned_after_display":"751,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-16","scope":"insider"},{"id":4528779,"accession":"0001123292-17-000694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-17-000694","line_url":"/filing/0001123292-17-000694#line-2","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6399.0,"shares_display":"6,399","price_per_share":8.0122,"price_display":"8.01","price_state":"stated","total_value":51270.0678,"total_display":"51,270.07","total_whole":"51,270","shares_owned_after":754263.0,"shares_owned_after_display":"754,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-16","scope":"insider"},{"id":4528773,"accession":"0001123292-17-000694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000694","line_url":"/filing/0001123292-17-000694#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5454.0,"shares_display":"5,454","price_per_share":8.0396,"price_display":"8.04","price_state":"stated","total_value":43847.9784,"total_display":"43,847.98","total_whole":"43,848","shares_owned_after":760662.0,"shares_owned_after_display":"760,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-14","filed_date":"2017-03-16","scope":"insider"},{"id":4813948,"accession":"0001123292-17-000452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000452","line_url":"/filing/0001123292-17-000452#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3334.0,"shares_display":"3,334","price_per_share":7.592,"price_display":"7.59","price_state":"stated","total_value":25311.728,"total_display":"25,311.73","total_whole":"25,312","shares_owned_after":766116.0,"shares_owned_after_display":"766,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-17","filed_date":"2017-02-21","scope":"insider"},{"id":5354246,"accession":"0001123292-17-000445","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-17-000445","line_url":"/filing/0001123292-17-000445#line-3","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":7.8572,"price_display":"7.86","price_state":"stated","total_value":8642.92,"total_display":"8,642.92","total_whole":"8,643","shares_owned_after":769450.0,"shares_owned_after_display":"769,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"},{"id":5354244,"accession":"0001123292-17-000445","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-17-000445","line_url":"/filing/0001123292-17-000445#line-2","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2164.0,"shares_display":"2,164","price_per_share":7.88,"price_display":"7.88","price_state":"stated","total_value":17052.32,"total_display":"17,052.32","total_whole":"17,052","shares_owned_after":770550.0,"shares_owned_after_display":"770,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-02-17","scope":"insider"},{"id":5354238,"accession":"0001123292-17-000445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000445","line_url":"/filing/0001123292-17-000445#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":766.0,"shares_display":"766","price_per_share":7.9559,"price_display":"7.96","price_state":"stated","total_value":6094.2194,"total_display":"6,094.22","total_whole":"6,094","shares_owned_after":772714.0,"shares_owned_after_display":"772,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-02-17","scope":"insider"},{"id":4697329,"accession":"0001123292-17-000428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000428","line_url":"/filing/0001123292-17-000428#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2651.0,"shares_display":"2,651","price_per_share":7.9704,"price_display":"7.97","price_state":"stated","total_value":21129.5304,"total_display":"21,129.53","total_whole":"21,130","shares_owned_after":773480.0,"shares_owned_after_display":"773,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-13","filed_date":"2017-02-15","scope":"insider"},{"id":2400635,"accession":"0001144204-16-120030","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-120030","line_url":"/filing/0001144204-16-120030","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J; SCP Vitalife II Associates, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14080.0,"shares_display":"14,080","price_per_share":6.306423948863636,"price_display":"6.31","price_state":"stated","total_value":88794.4492,"total_display":"88,794.45","total_whole":"88,794","shares_owned_after":361682.0,"shares_owned_after_display":"361,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-17","scope":"insider","n_lines":2},{"id":2400623,"accession":"0001144204-16-120030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-120030","line_url":"/filing/0001144204-16-120030#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J; SCP Vitalife II Associates, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10958.0,"shares_display":"10,958","price_per_share":6.4483,"price_display":"6.45","price_state":"stated","total_value":70660.4714,"total_display":"70,660.47","total_whole":"70,660","shares_owned_after":375762.0,"shares_owned_after_display":"375,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider"},{"id":2966752,"accession":"0001144204-16-107109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-107109","line_url":"/filing/0001144204-16-107109#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife II Associates, L.P.; LUDOMIRSKI ABRAHAM; SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.; CHURCHILL WINSTON J","owner_display_name":"SCP Vitalife II Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1324.0,"shares_display":"1,324","price_per_share":7.8961,"price_display":"7.90","price_state":"stated","total_value":10454.4364,"total_display":"10,454.44","total_whole":"10,454","shares_owned_after":386720.0,"shares_owned_after_display":"386,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-03","filed_date":"2016-06-06","scope":"insider"},{"id":2966748,"accession":"0001144204-16-107109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-107109","line_url":"/filing/0001144204-16-107109#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife II Associates, L.P.; LUDOMIRSKI ABRAHAM; SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.; CHURCHILL WINSTON J","owner_display_name":"SCP Vitalife II Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3448.0,"shares_display":"3,448","price_per_share":7.8911,"price_display":"7.89","price_state":"stated","total_value":27208.5128,"total_display":"27,208.51","total_whole":"27,209","shares_owned_after":388044.0,"shares_owned_after_display":"388,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-06","scope":"insider"},{"id":2441323,"accession":"0001144204-16-106508","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-106508","line_url":"/filing/0001144204-16-106508#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J; SCP Vitalife II Associates, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1570.0,"shares_display":"1,570","price_per_share":7.5788,"price_display":"7.58","price_state":"stated","total_value":11898.716,"total_display":"11,898.72","total_whole":"11,899","shares_owned_after":391492.0,"shares_owned_after_display":"391,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-02","scope":"insider"},{"id":2441319,"accession":"0001144204-16-106508","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-106508","line_url":"/filing/0001144204-16-106508#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J; SCP Vitalife II Associates, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1277.0,"shares_display":"1,277","price_per_share":7.941,"price_display":"7.94","price_state":"stated","total_value":10140.657,"total_display":"10,140.66","total_whole":"10,141","shares_owned_after":393062.0,"shares_owned_after_display":"393,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider"},{"id":2333277,"accession":"0001144204-16-105624","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-105624","line_url":"/filing/0001144204-16-105624#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.; CHURCHILL WINSTON J; SCP Vitalife II Associates, L.P.; LUDOMIRSKI ABRAHAM","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3756.0,"shares_display":"3,756","price_per_share":8.6071,"price_display":"8.61","price_state":"stated","total_value":32328.2676,"total_display":"32,328.27","total_whole":"32,328","shares_owned_after":394339.0,"shares_owned_after_display":"394,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-27","scope":"insider"},{"id":2333274,"accession":"0001144204-16-105624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-105624","line_url":"/filing/0001144204-16-105624#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.; CHURCHILL WINSTON J; SCP Vitalife II Associates, L.P.; LUDOMIRSKI ABRAHAM","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3010.0,"shares_display":"3,010","price_per_share":8.7972,"price_display":"8.80","price_state":"stated","total_value":26479.572,"total_display":"26,479.57","total_whole":"26,480","shares_owned_after":398095.0,"shares_owned_after_display":"398,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-27","scope":"insider"},{"id":2089855,"accession":"0001144204-16-104905","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-104905","line_url":"/filing/0001144204-16-104905#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife II Associates, L.P.; CHURCHILL WINSTON J; LUDOMIRSKI ABRAHAM; SCP Vitalife II GP, Ltd.; SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife II Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":8.95,"price_display":"8.95","price_state":"stated","total_value":447.5,"total_display":"447.50","total_whole":"448","shares_owned_after":401105.0,"shares_owned_after_display":"401,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-24","filed_date":"2016-05-25","scope":"insider"},{"id":2724638,"accession":"0001123292-16-002338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-002338","line_url":"/filing/0001123292-16-002338#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2503.0,"shares_display":"2,503","price_per_share":6.3001,"price_display":"6.30","price_state":"stated","total_value":15769.1503,"total_display":"15,769.15","total_whole":"15,769","shares_owned_after":776131.0,"shares_owned_after_display":"776,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-25","scope":"insider"},{"id":2089852,"accession":"0001144204-16-104905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-104905","line_url":"/filing/0001144204-16-104905#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife II Associates, L.P.; CHURCHILL WINSTON J; LUDOMIRSKI ABRAHAM; SCP Vitalife II GP, Ltd.; SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife II Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":2700.0,"total_display":"2,700.00","total_whole":"2,700","shares_owned_after":401155.0,"shares_owned_after_display":"401,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-25","scope":"insider"},{"id":2287835,"accession":"0001144204-16-104288","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-104288","line_url":"/filing/0001144204-16-104288#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.; SCP Vitalife II Associates, L.P.; CHURCHILL WINSTON J; LUDOMIRSKI ABRAHAM","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2791.0,"shares_display":"2,791","price_per_share":9.0788,"price_display":"9.08","price_state":"stated","total_value":25338.9308,"total_display":"25,338.93","total_whole":"25,339","shares_owned_after":401455.0,"shares_owned_after_display":"401,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-23","scope":"insider"},{"id":2093902,"accession":"0001123292-16-002312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-16-002312","line_url":"/filing/0001123292-16-002312#line-2","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5008.0,"shares_display":"5,008","price_per_share":6.4548,"price_display":"6.45","price_state":"stated","total_value":32325.6384,"total_display":"32,325.64","total_whole":"32,326","shares_owned_after":778634.0,"shares_owned_after_display":"778,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-23","scope":"insider"},{"id":2287831,"accession":"0001144204-16-104288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-104288","line_url":"/filing/0001144204-16-104288#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; SCP Vitalife II GP, Ltd.; SCP Vitalife II Associates, L.P.; CHURCHILL WINSTON J; LUDOMIRSKI ABRAHAM","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1252.0,"shares_display":"1,252","price_per_share":9.119,"price_display":"9.12","price_state":"stated","total_value":11416.988,"total_display":"11,416.99","total_whole":"11,417","shares_owned_after":404246.0,"shares_owned_after_display":"404,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-19","filed_date":"2016-05-23","scope":"insider"},{"id":2093899,"accession":"0001123292-16-002312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-002312","line_url":"/filing/0001123292-16-002312#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1252.0,"shares_display":"1,252","price_per_share":6.4559,"price_display":"6.46","price_state":"stated","total_value":8082.7868,"total_display":"8,082.79","total_whole":"8,083","shares_owned_after":783642.0,"shares_owned_after_display":"783,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-19","filed_date":"2016-05-23","scope":"insider"},{"id":3048177,"accession":"0001144204-16-076262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-076262","line_url":"/filing/0001144204-16-076262#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners (Israel) II, L.P.; CHURCHILL WINSTON J; SCP Vitalife II GP, Ltd.; SCP Vitalife II Associates, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12519.0,"shares_display":"12,519","price_per_share":10.2968,"price_display":"10.30","price_state":"stated","total_value":128905.6392,"total_display":"128,905.64","total_whole":"128,906","shares_owned_after":405498.0,"shares_owned_after_display":"405,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-15","filed_date":"2016-01-20","scope":"insider"},{"id":8792042,"accession":"0001192482-15-000430","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-15-000430","line_url":"/filing/0001192482-15-000430#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":1350.0,"total_display":"1,350.00","total_whole":"1,350","shares_owned_after":784894.0,"shares_owned_after_display":"784,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-30","filed_date":"2015-12-01","scope":"insider"},{"id":8863905,"accession":"0001192482-15-000429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-15-000429","line_url":"/filing/0001192482-15-000429#line-2","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":9.0009,"price_display":"9.00","price_state":"stated","total_value":20252.025,"total_display":"20,252.02","total_whole":"20,252","shares_owned_after":785044.0,"shares_owned_after_display":"785,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-27","filed_date":"2015-11-30","scope":"insider"},{"id":8863902,"accession":"0001192482-15-000429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-15-000429","line_url":"/filing/0001192482-15-000429#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1553.0,"shares_display":"1,553","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":13977.0,"total_display":"13,977.00","total_whole":"13,977","shares_owned_after":787294.0,"shares_owned_after_display":"787,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-25","filed_date":"2015-11-30","scope":"insider"},{"id":8917442,"accession":"0001192482-15-000426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-15-000426","line_url":"/filing/0001192482-15-000426#line-2","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":691.0,"shares_display":"691","price_per_share":9.006,"price_display":"9.01","price_state":"stated","total_value":6223.146,"total_display":"6,223.15","total_whole":"6,223","shares_owned_after":788847.0,"shares_owned_after_display":"788,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-24","filed_date":"2015-11-25","scope":"insider"},{"id":8917440,"accession":"0001192482-15-000426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-15-000426","line_url":"/filing/0001192482-15-000426#line-1","is_derivative":false,"issuer_cik":"0001588972","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001588972","owner_cik":"0001602484","owner_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_display_name":"SCP Vitalife Partners (Israel) II, L.P.","owner_url":"/insider/0001602484","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3702.0,"shares_display":"3,702","price_per_share":9.0009,"price_display":"9.00","price_state":"stated","total_value":33321.3318,"total_display":"33,321.33","total_whole":"33,321","shares_owned_after":789538.0,"shares_owned_after_display":"789,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-23","filed_date":"2015-11-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Ten percent owner","n_filings":15,"first_seen":"2015-11-25","last_seen":"2020-12-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001607962","name":"ReWalk Robotics Ltd.","url":"/issuer/0001607962","role":"Ten percent owner","n_filings":8,"first_seen":"2016-01-20","last_seen":"2017-06-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001602484","retrieved_at":"2026-08-23T16:43:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}